Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Thy study's objective is to to collect data regarding the ability to achieve solide fusion, comibing the GO-LIF procedure for spinal fixation and stabilization with percutaneous posterior facets fusion.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Study of the GO-LIF® Approach for Lumbar Spinal Fixation
NCT00810433
Comparison of Standard Fusion With "Topping Off"-System in Lumbar Spine
NCT01224379
A Post-Market Study of Transfacet Lumbar Spine Fixation and Fusion Utilizing the PERPOS™ PLS System
NCT00887835
A Pivotal Study of the Premia Spine TOPS™ System
NCT03012776
3Spine Lumbar Fusion Real World Evidence Study
NCT04823858
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GO-LIF procedure, posetrior facets fusion
No interventions assigned to this group
solid fusion, GO-LIF procedure
ability to achieve solid fusion, comibing the GO-LIF procedure for spinal fixation and stabilization with percutaneous posetrior facets fusion
GO-LIF and SpineAssist SYSTEMS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GO-LIF and SpineAssist SYSTEMS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Men and women, 18-80 years of age.
3. Unequivocal medical indication for the fixation surgery of a single motion segment of the lumbar spine.
4. Correct coronal profile of the lumbar spine. An asymmetric collapse of the disk space in the coronal plane between the vertebral bodies envisioned for instrumentation is by itself not an exclusion criterion.
5. Patient may have, but is not required to, secondary diagnosis of any one of the following:
* Degenerative spondylolisthesis (Grades 1 and 2) in the sagittal plane with preserved or normal sagittal alignment
* Spinal stenosis (Not excluding patient with a need to decompression )
6. ODI cut-off for inclusion, lower than or equal to 40 for ODI
7. VAS cut-off for inclusion, lower than or equal to 9
8. Patient is willing and able to comply with study requirements, including follow-up schedule and postoperative management program
9. Patient must understand and sign informed consent
Exclusion Criteria
2. Deformities of the vertebral bodies envisioned for instrumentation or the sacrum.
3. Spondylolisthesis \> grade 2 acc. to Meyerding.
4. Scoliosis and other deformities in the coronal plane.
5. Fractures of the vertebrae envisioned for instrumentation.
6. Osteoporosis or osteopenia (see below for examination criteria).
7. Therapy with systemic corticosteroids or immunosuppressants.
8. Bone metabolism diseases, such as osteomalacia or Paget's disease.
9. Post inflammatory instability of the vertebral spine.
10. State after radiation therapy of the relevant vertebral spine region.
11. Current Marcoumar or heparin therapy for more than 6 months at the time of operation.
12. Malignant diseases with or without bone metastases.
13. Immunologic-inflammatory diseases (e.g., rheumatoid arthritis).
14. Diabetes mellitus.
15. Infectious diseases.
16. More than one motion segments requiring treatment.
17. Prior percutaneous vertebral augmentation procedure (e.g., vertebroplasty, kyphoplasty) at index or adjacent level.
18. Prior fusion attempts at the involved levels.
19. Clinically or radiographically compromised vertebral bodies at the superior vertebra of the affected level or compromised pedicles at the inferior vertebra of the affected level due to current or past trauma such that a Onyx Spinal System can not be implanted
20. Active malignancy: A patient with a history of any invasive malignancy (except non-melanoma skin cancer), unless he/she has been treated with curative intent and there has been no clinical signs or symptoms of the malignancy for at least 5 years.
21. Coagulopathy or inability to reverse anti-coagulant therapy (both during and approximately 24 hours post-procedure).
22. Metabolic bone disease such as Paget's disease, osteopenia or osteomalacia.
23. Severe diabetes mellitus requiring daily insulin management.
24. Haemorrhagic diasthesis.
25. Coagulation disorders, or severe cardiopulmonary disease.
26. Active systemic infection (including AIDS, HIV and Hepatitis) or active infection at surgical site.
27. Rheumatoid arthritis or other autoimmune disease.
28. Morbid obesity, defined as having a Body Mass Index of 40 or higher or more than 100 pounds over weight.
29. Conditions or medications that may interfere with bony/soft tissue healing (e.g., long term steroid use).
30. Any medical condition that would preclude the patient from having surgery, impede the benefit of spinal implant surgery or impede the patient from completing the post operative rehabilitation plan.
31. Pregnancy, current or planned during the duration of the study.
32. Subject has a history of substance abuse (e.g., recreational drugs, narcotics, or alcohol) within the last 12 months.
33. Known allergy to titanium or titanium alloys.
34. Bone growth stimulator use anywhere in the body within the last 30 days.
35. In active spinal litigation.
36. Degenerative spondylolisthesis (Grades 3 and above)
37. Is currently involved in a study of another investigational product for similar purpose
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hadassah Medical Organization
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hadassah Medical Organization
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hadassah Medical Organizaton
Jerusalem, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BARZ-004-HMO-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.